D'ANGELO, Emanuela
 Distribuzione geografica
Continente #
NA - Nord America 997
EU - Europa 570
AS - Asia 273
SA - Sud America 3
AF - Africa 2
Totale 1.845
Nazione #
US - Stati Uniti d'America 984
IE - Irlanda 226
SG - Singapore 188
IT - Italia 171
SE - Svezia 74
CN - Cina 57
RU - Federazione Russa 36
GB - Regno Unito 11
FI - Finlandia 9
BE - Belgio 8
CA - Canada 8
DE - Germania 8
TR - Turchia 7
ES - Italia 5
JP - Giappone 5
PL - Polonia 4
VN - Vietnam 4
CU - Cuba 3
IN - India 3
LT - Lituania 3
BG - Bulgaria 2
BR - Brasile 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
IL - Israele 2
KR - Corea 2
TW - Taiwan 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BS - Bahamas 1
EG - Egitto 1
FR - Francia 1
GE - Georgia 1
HK - Hong Kong 1
NL - Olanda 1
PA - Panama 1
PE - Perù 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 1.845
Città #
Chandler 292
Dublin 226
Singapore 166
Ashburn 101
Princeton 66
Jacksonville 58
Altamura 35
Santa Clara 27
Wilmington 26
Pescara 22
Los Angeles 14
Falls Church 13
Washington 13
Chieti 12
New York 12
Milan 10
Pavia 10
Rome 9
Brussels 8
Ann Arbor 7
Ascoli Piceno 7
Kocaeli 7
Boardman 6
Lappeenranta 6
Shenzhen 6
Dong Ket 4
Montreal 4
Nanjing 4
Norwalk 4
Toronto 4
Chengdu 3
Dallas 3
Edinburgh 3
Guangzhou 3
Havana 3
Helsinki 3
London 3
Tokyo 3
Avezzano 2
Barbarano Vicentino 2
Beijing 2
Boston 2
Corridonia 2
Dongguan 2
Frankfurt am Main 2
Goyang-si 2
Guglionesi 2
Hangzhou 2
Hyderabad 2
Karasawa 2
Klausen 2
Madrid 2
Riccia 2
Romola 2
Roseto degli Abruzzi 2
Seattle 2
Sofia 2
Stanford 2
Stockholm 2
São Paulo 2
Taipei 2
Xi'an 2
Zurich 2
Atlanta 1
Bend 1
Bhubaneswar 1
Birmingham 1
Bologna 1
Brno 1
Buckingham 1
Campodipietra 1
Casalbordino 1
Changsha 1
Chicago 1
Cincinnati 1
Cosenza 1
Dalmine 1
Dubai 1
Ercolano 1
Flero 1
Florence 1
Fornovo San Giovanni 1
Fort Collins 1
Fuzhou 1
Galati 1
Gergei 1
Guardialfiera 1
Harbin 1
Jerusalem 1
Jieyang 1
Jinan 1
Jining 1
Kunming 1
LaPorte 1
Lanciano 1
Lanzhou 1
Louisville 1
Macerata 1
Modena 1
Moscow 1
Totale 1.290
Nome #
Involvement of DNA Base Excision Repair (BER) in Early Stages of Thyroid Carcinogenesis and Its Correlations with Clinical Features and Inflammatory Microenvironment 68
Endometrial stromal sarcomas with sex cord differentiation are associated with phf1 rearrangement 61
Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study 60
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type 60
Endometrioid endometrial carcinomas with microcystic, elongated, and fragmented (MELF) type of myoinvasion: role of immunohistochemistry in the detection of occult lymph node metastases and their clinical significance 59
Uterine sarcomas: A review 58
Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations 58
POLE exonuclease domain mutations in endometrial carcinoma: a case report 57
Expression profiling of 22 genes involved in the PI3K-AKT pathway identifies two subgroups of high-grade endometrial carcinomas with different molecular alterations 57
Classification of ovarian carcinomas based on pathology and molecular genetics 56
Stromal signatures in endometrioid endometrial carcinomas 56
A surprising evolution from oral human papillomavirus 16 infection to lymph node metastasis of tonsilar squamous cell carcinoma in an HIV-infected patient 56
Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system 53
Myometrial invasion and lymph node metastasis in endometrioid carcinomas: Tumor-associated macrophages, microvessel density, and HIF1A have a crucial role 53
Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells 50
Diagnostic use of immunohistochemistry in uterine mesenchymal tumors 50
Loss-of-function variants in myocardin cause congenital megabladder in humans and mice 49
The FOXO1-miR27 tandem regulates myometrial invasion in endometrioid endometrial adenocarcinoma 49
Gene expression analysis identifies two groups of ovarian high-grade serous carcinomas with different prognosis 49
The fibroid as clinical problem 48
Placental site trophoblastic tumor (PSTT): a case report and review of the literature 47
Uterine leiomyosarcomas: Tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis 47
Molecular analyses of juvenile granulosa cell tumors bearing AKT1 mutations provide insights into tumor biology and therapeutic leads 46
CD8 down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomas 46
Mixed and ambiguous endometrial carcinomas 44
Pathology of mixed Müllerian tumours 44
null 43
Squamous cell carcinoma of the ovary arising from a mucinous cystic tumor of endocervical (Müllerian) type 42
Simultaneous carcinomas of the breast and ovary: Utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases 41
Undifferentiated and Dedifferentiated Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis 40
Atypical Endometrial Hyperplasia, Low-grade: "Much ADO About Nothing" 40
Placental histopathology after SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis 40
Mixed endometrial carcinomas with a “low-grade serous”–like component: a clinicopathologic, immunohistochemical, and molecular genetic study 38
Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary 35
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4 32
BRCA gene amplification in primary peritoneal high-grade serous carcinoma patient with intrinsic resistance to platinum treatment: a case report 26
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma 26
Extracellular vesicles during the three trimesters of pregnancy 22
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma—A Study by the Spanish Group for Ovarian Cancer Research (GEICO) 21
19. Uterine smooth muscle tumors. 21
12. Cervical glandular neoplasia 21
31. The Peritoneum 21
Brenner Tumors and Transitional Cell Tumors of the Ovary. 18
30. Metastatic tumors of the ovary. 17
Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics 16
Erratum: Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4 (Nature Genetics (2014) 46 (427-429)) 15
Diagnostic challenges in endocervical adenocarcinoma 15
Malignant rhabdoid tumors of the vulva versus epithelioid sarcomas: a clinicopathologic, immunohistochemical, and molecular genetics study 13
Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor 12
Endometrial carcinoma: 10 years of TCGA (the cancer genome atlas): A critical reappraisal with comments on FIGO 2023 staging 11
Ovarian Cancer: Pathology and Genetics 5
Ovarian Mixed Epithelial–Stromal Tumors 4
Pathological pathway adaptations for adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA).|Adattamenti dei percorsi patologici in funzione del trattamento con osimertinib in adiuvante nei pazienti con NSCLC in stadio precoce (IB-IIIA) 4
Non-neoplastic and Tumor-like Conditions of the Ovary. 4
Role of frozen section in Gynecology Oncology 3
Totale 2.027
Categoria #
all - tutte 11.955
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.955


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202037 0 0 0 0 0 0 0 0 0 0 0 37
2020/2021184 5 20 81 13 8 29 5 1 2 7 6 7
2021/2022183 10 2 0 3 6 13 3 10 18 7 21 90
2022/2023720 86 121 31 78 48 115 44 63 74 5 39 16
2023/2024484 28 17 34 11 27 149 116 31 13 24 7 27
2024/2025419 68 154 93 23 31 50 0 0 0 0 0 0
Totale 2.027